5G Challenges of Ethics Committee Functioning During Pandemic and A Case Study of 40 Hospitals

Umar Danjuma Maiwada¹ , Abubakar Danjuma Maiwada² , Mujaheed Abdullahi³

Section:Review Paper, Product Type: Journal-Paper
Vol.12 , Issue.1 , pp.17-25, Feb-2024

Online published on Feb 28, 2024

Copyright © Umar Danjuma Maiwada, Abubakar Danjuma Maiwada, Mujaheed Abdullahi . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
This study investigates the challenges faced by ethics committees in relation to the COVID-19 epidemic and the 5G network, focusing on their operational functioning. The research involves a comprehensive examination of the ethical considerations and decision-making processes encountered by these committees within the high-speed, low-latency environment of 5G. Additionally, the study presents a case analysis encompassing 40 hospitals, shedding light on the practical implications and experiences of ethics committees during the pandemic. By delving into these challenges and the case study, this research aims to provide insights into the intersection of healthcare ethics, technological infrastructure, and crisis management, offering valuable perspectives for future preparedness and ethical governance in similar contexts. The EC is a self-regulating body that is primarily responsible for guaranteeing the protection of experimental study individuals` privileges, security, and welfare. It guarantees that all ethical components of project concepts are thoroughly examined by experts and ensures this investigation is conducted in an unbiased and objective manner. The EC faces several challenges, especially during the pandemic, the prolonged lockdown, and the unforeseeable advent of the pandemic avoiding the EC of an SOP to deal with the situation. While there is a specified procedure for amending SOPs, which involves meeting in person, there is no provision for online meetings to amend SOPs, project reviews, and/or decision-making. Other issues facing the EC are the operation of the Office, there is reduced availability to deal with urgent regulatory problems for office workers, and dealing with epidemic-related programs for analysis which needs urgency. This study aims to identify the challenges faced by the EC in different hospitals across India. Also, identify any common challenges faced across the hospitals and derive lessons learned and best practices for future pandemic responses. We analyze the decision-making processes of ethics committees in these hospitals, especially in situations where rapid decisions were required.

Key-Words / Index Term :
Ethics Committee, Challenges, Pandemic, Functioning, IEC, IRB

References :
[1] Dent NJ, Krishan A., “Ethics committees in India.”, Quality Assurance Journal, Vol 11: pp 143–50, 2007.
[2] Bavdekar S., “Ethics committees: Actions during pandemic And lockdown situations.”, Journal of Postgraduate Medicine, vol 66: pp 119–22., 2020.
[3] Dashraath P, Jeslyn WJL, Karen LMX, Min LL, Sarah L, Biswas A, et al., “Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.”, American Journal of Obstetrics and Gynecology, 2020.
[4] Kadam R, Karandikar S., “Ethics committees in India: Facing the challenges!”, Perspectives in Clinical Research, pp 3:50., 2012.
[5] Osborne TL, Luoma JB., “Overcoming a primary barrier to practice-based research:”, Access to an institutional review board (IRB) for independent ethics review. Psychotherapy, pp 55:255., 2018.
[6] Thatte UM, Marathe P., “Ethics Committees in India: Past, present and future.”, Perspectives in Clinical Research, Vol 8: pp 22–30., 2017.
[7] Pandiya A., “Quality of independent review board/ethics committee oversight in clinical trials in India.”, Perspectives in Clinical Research, pp 2:45., 2011.
[8] Ellenberg SS., “Clinical trials in the time of a pandemic.”, Clinical Trials, Vol 17: pp 467–71., 2020.
[9] Hick JL, Pavia AT., “Duty to Plan: Health Care”, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2., 2020.
[10] Gostin LO, Hanfling D, Hanson SL, Stroud C, “Altevogt BM.”, Guidance for establishing crisis standards of care for use in disaster situations: A letter report. National Academies Press, 2009.
[11] Berlinger N, Wynia M, Powell T, Micah Hester D, Milliken A, Fabi R, et al., “Ethical Framework for Health Care Institutions Responding to Novel Coronavirus SARS-CoV-2 (COVID-19) Guidelines for Institutional Ethics Services Responding to COVID-19 Managing Uncertainty”, Safeguarding Communities, Guiding Practice., 2020.
[12] Milliken A, Jurchak M, Sadovnikoff N, Feldman WB, Shah SB, Galluzzo M, et al., “Addressing Challenges Associated with Operationalizing a Crisis Standards of Care”, Protocol for the Covid-19 Pandemic, 2020.
[13] Perez GIP, Abadi ATB., “Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.”, Archives of Medical Research, 2020.
[14] Del Rio C, Malani PN., “COVID-19 - New Insights on a Rapidly Changing Epidemic.”, JAMA - Journal of the American Medical Association, Vol 323: PP 1339–40., 2020.
[15] Lara E. T, “Coronavirus disease 2019 (COVID-19)”, Situation Report-72 HIGHLIGHTS. n.d., 2019.
[16] Giacomo G, Antonio P, Maurizio C., “Critical Care Utilization for the COVID-19 Outbreak in Lombardy”, Italy JAMA, Vol 323: pp 1545., 2020.
[17] Thatte UM, Bavdekar SB., “Clinical research in India: Great expectations?”, Journal of Postgraduate Medicine, pp 54:318., 2008.
[18] A. Hendrick, “Constitution of ECs and role of EC members.”, Journal of clinical medicine n.d., 2006.
[19] Muthuswamy V., “Status of ethical review and challenges in India.”, Indian Pediatrics, Vol 42: pp 1189., 2005.
[20] Lynch HF, Abdirisak M, Bogia M, Clapp J., “Evaluating the quality of research ethics review and oversight: a systematic analysis of quality assessment instruments.”, AJOB Empirical Bioethics, pp 1–15., 2020.
[21] Agrawal V, Nath C, Mishra SK., “Ethics committee meeting by videoconferencing during Covid-19”, Journal of Internal Medicine, 2020.
[22] MM Rahman, F Khatun, SI Sami, A Uzzaman, “The evolving roles and impacts of 5G enabled technologies in healthcare: The world epidemic COVID-19 issues”, Elsevier Elsevier, 2020.
[23] A Moglia, K Georgiou, B Marinov, “5G in healthcare: from COVID-19 to future challenges”, IEEE Journal explore, 2022.
[24] Y Siriwardhana, G Gür, M Ylianttila, M Liyanage, “The role of 5G for digital healthcare against COVID-19 pandemic: Opportunities and challenges”, Elsevier, 2021.
[25] V Chamola, V Hassija, V Gupta, M Guizani, “A comprehensive review of the COVID-19 pandemic and the role of IoT, drones, AI, blockchain, and 5G in managing its impact”, IEEE Access Journal, 2020.
[26] MM Rahman, F Khatun, “Challenges and Prospective of AI and 5G-Enabled Technologies in Emerging Applications during the Pandemic”, intechopen Journal, 2023.